Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
January 10, 2020 Off

Novus Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds

By BusinessWire

IRVINE, Calif.–(BUSINESS WIRE)–$NVUS #otitismedia–Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders…

January 10, 2020 Off

NeuroBo Pharmaceuticals and Gemphire Therapeutics Complete Merger

By BusinessWire

– Shares of the Combined Company, NeuroBo Pharmaceuticals, Began Trading on the Nasdaq Exchange Under the Symbol NRBO on December…

January 10, 2020 Off

Veeva to Present at the 38th Annual J.P. Morgan Healthcare Conference

By BusinessWire

PLEASANTON, Calif.–(BUSINESS WIRE)–Veeva Systems (NYSE:VEEV) today announced that Paul Shawah, SVP of Veeva Commercial Cloud, will present at the 38th…

January 10, 2020 Off

Alnylam Initiates Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Lumasiran for the Treatment of Primary Hyperoxaluria Type 1 (PH1)

By BusinessWire

− Company Plans to Complete Submission in Early 2020 – – Lumasiran Granted Pediatric Rare Disease Designation by FDA for…

January 10, 2020 Off

Janssen Expands Research & Development Presence with Major Investment in South San Francisco

By BusinessWire

Investment delivers on overall strategy to expand pharmaceutical research and development footprint and enhance presence in critical innovation hotbed NEW…

January 10, 2020 Off

CORRECTING and REPLACING REVIAN® Inc. Announces Issuance of Landmark Patent Covering the Use of Light to Stimulate the Body to Heal Itself

By BusinessWire

Leads to first all-LED medical device that regenerates hair. No chemicals. No pills. Just light. DURHAM, N.C.–(BUSINESS WIRE)–The patent number…

January 10, 2020 Off

PQ Bypass Announces 100th Patient in Clinical Study to Evaluate Percutaneous Fem-Pop Bypass for Extremely Long Blockages in Leg Arteries

By BusinessWire

DETOUR Procedure Designed to Move Treatment from Inpatient to Outpatient Setting MILPITAS, Calif.–(BUSINESS WIRE)–#ClinicalTrial–Silicon Valley-based medical device company PQ Bypass…

January 10, 2020 Off

Taro Pharmaceuticals U.S.A., Inc. Issues Voluntary Nationwide Recall of Lamotrigine Tablets USP, 100 mg, 100 Count Bottles

By BusinessWire

(NDC 51672-4131-1) Lot # 331771 (Expiration June 2021) Due to Cross-Contamination With Enalapril Maleate HAWTHORNE, N.Y.–(BUSINESS WIRE)–Taro Pharmaceuticals U.S.A., Inc.…

January 10, 2020 Off

Alydia Health Announces the Addition of Erica Rogers to its Board of Directors

By BusinessWire

Seasoned Medical Device Executive Brings Product Development and Commercialization Expertise MENLO PARK, Calif.–(BUSINESS WIRE)–Alydia Health, a clinical-stage medical device company…

January 10, 2020 Off

Quanterix Corporation to Present at 38th Annual J.P. Morgan Healthcare Conference

By BusinessWire

Company continues remarkable growth in 2019, fueled by new product launches, the acquisition of UmanDiagnostics, further validation in ground-breaking publications…

Posts pagination

Previous 1 … 5,208 5,209 5,210 … 6,215 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Rare Diseases Treatment Market Analysis and Forecast 2025-2032: A $45.8 Billion Opportunity – Complex Challenges and Unprecedented Opportunities are Emerging – ResearchAndMarkets.com

December 19, 2025 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine